Rio Tinto Chief Executive Simon Trott said: "Safety is the foundation of our business. The tragic loss of two colleagues this year, at Simandou and Kennecott, is a stark reminder that we must ensure ...
Rio Tinto Chief Executive Simon Trott said: "Safety is the foundation of our business. The tragic loss of two colleagues this year, at Simandou and ...
Abogen, a clinical-stage biotechnology company focused on RNA innovation, today announced preliminary clinical results from the first-in-human (FIH) study of ABO2203 in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results